Silvia Romano | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Clinical manifestations of intermediate allele carriers in Huntington disease	NEUROLOGY	2016
Progression of motor subtypes in Huntington’s disease. a 6-year follow-up study	JOURNAL OF NEUROLOGY	2016
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study	MULTIPLE SCLEROSIS	2016
Riluzole in patients with hereditary cerebellar ataxia. Authors' reply	LANCET NEUROLOGY	2016
Spinocerebellar ataxia type 3 in Italy. time to change mind	NEUROEPIDEMIOLOGY	2016
Vaccines in multiple sclerosis. The experience of BCG vaccination	DRUGS OF THE FUTURE	2016
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2016
Exploring the structural relationship between interviewer and self-rated affective symptoms in Huntington’s disease	THE JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES	2016
Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease. A European population study	JOURNAL OF PSYCHOSOMATIC RESEARCH	2016
Conversion from clinically isolated syndrome to multiple sclerosis. a large multicentre study.	MULTIPLE SCLEROSIS	2015
IFN-β and multiple sclerosis: From etiology to therapy and back	CYTOKINE & GROWTH FACTOR REVIEWS	2015
Epstein-Barr virus genetic variants are associated with multiple sclerosis	NEUROLOGY	2015
IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status	JOURNAL OF INTERFERON AND CYTOKINE RESEARCH	2015
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial	LANCET NEUROLOGY	2015
Exploring genetic factors involved in huntington disease age of onset. E2F2 as a new potential modifier gene	PLOS ONE	2015
The role of tau in the pathological process and clinical expression of Huntington's disease	BRAIN	2015
Analyzing the effects of a G137V mutation in the FXN gene	FRONTIERS IN MOLECULAR NEUROSCIENCE	2015
Factor analysis of the hospital anxiety and depression scale among a Huntington's disease population	MOVEMENT DISORDERS	2015
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease	NATURE NEUROSCIENCE	2015
Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease	JOURNAL OF HUNTINGTON'S DISEASE	2015

ERC

LS5_11

Interessi di ricerca

Diagnosi, terapia e classificazione fenotipica delle atassie cerebellari ereditarie
Diagnosi, terapia e classificazione fenotipica idelle paraparesi spastiche ereditarie
Diagnosi, terapia e classificazione fenotipica idelle malattie monogeniche dei piccoli vasi (CADASIL, CARASIL)
Ricerca di biomarcatori circolanti nella Malattia di Huntington